BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

From NeuroBo to MetaVia (MTVA): This Biotech Just Went All-In on Obesity and Liver Disease

  • BioTech Health X
  • July 23, 2025
MetaVia Inc. (NASDAQ:MTVA), formerly NeuroBo Pharmaceuticals, Inc, is a clinical-stage biotechnology company focused on developing next-generation therapies for…
Read More
0 Shares
0
0
0
0
0
0
0

Alterity Therapeutics (ATHE) is One FDA Meeting Away From a Major Breakout

  • BioTech Health X
  • July 23, 2025
Alterity Therapeutics Ltd. (NASDAQ:ATHE) is a clinical-stage biotechnology company headquartered in Melbourne, Australia, focused on developing innovative therapies…
Read More
0 Shares
0
0
0
0
0
0
0

Liminatus Pharma (LIMN) Might Be the Most Disruptive Micro-Cap on NASDAQ

  • BioTech Health X
  • July 23, 2025
Liminatus Pharma Inc. (NASDAQ:LIMN) is a preclinical-stage biopharmaceutical company dedicated to the discovery and development of targeted cancer…
Read More
0 Shares
0
0
0
0
0
0
0

Thermo Fisher (TMO) Is Everywhere—And That’s Exactly Why It’s Winning

  • BioTech Health X
  • July 23, 2025
Thermo Fisher Scientific Inc (NYSE:TMO) is a global leader in the scientific and healthcare solutions industry, renowned for…
Read More
0 Shares
0
0
0
0
0
0
0

Krystal Biotech (KRYS) Just Changed Gene Therapy Forever—Smart Investors Are Paying Attention

  • BioTech Health X
  • July 22, 2025
Krystal Biotech, Inc. (NASDAQ: KRYS) is a cutting-edge biotechnology company pioneering the development of redosable genetic medicines aimed…
Read More
0 Shares
0
0
0
0
0
0
0

Seres Therapeutics (MCRB): The $100M Microbiome Gem Flying Under Wall Street’s Radar

  • BioTech Health X
  • July 22, 2025
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneering biotechnology company at the forefront of developing microbiome therapeutics—a groundbreaking class…
Read More
0 Shares
0
0
0
0
0
0
0

Telesurgery Is Here—and Intuitive Surgical (ISRG) Owns It

  • BioTech Health X
  • July 22, 2025
Intuitive Surgical, Inc., founded in 1995 and headquartered in Sunnyvale, California, is a trailblazer in the field of…
Read More
0 Shares
0
0
0
0
0
0
0

Medpace (MEDP) Just Soared 50%—Is This the Most Underrated Biotech Play of 2025?

  • BioTech Health X
  • July 22, 2025
Medpace Holdings Inc. (NASDAQ:MEDP) is a leading global contract research organization (CRO) that partners with biopharmaceutical, biotechnology, and…
Read More
0 Shares
0
0
0
0
0
0
0

TransMedics (TMDX) Could Be the Tesla of Transplants — Here’s Why Investors Are Paying Attention

  • BioTech Health X
  • July 21, 2025
TransMedics Group, Inc. (NASDAQ:TMDX) is a pioneering medical technology company that is fundamentally transforming the landscape of organ…
Read More
0 Shares
0
0
0
0
0
0
0

Astera Labs (ALAB) is Down from Highs — But Here’s Why It’s About to Rebound Hard

  • BioTech Health X
  • July 21, 2025
Astera Labs Inc. (NASDAQ:ALAB) is a rapidly emerging leader in intelligent connectivity solutions designed to address the unique…
Read More
0 Shares
0
0
0
0
0
0
0

Wall Street Sees 75% Upside: Is Replimune (REPL) the Best Biotech Stock to Buy Now?

  • BioTech Health X
  • July 21, 2025
Replimune Group, Inc. (NASDAQ:REPL) is a biotechnology company pioneering a transformative class of cancer therapeutics based on its…
Read More
0 Shares
0
0
0
0
0
0
0

Smart Investors Are Loading Up on GlucoTrack (GCTK) Before Q3 Milestones

  • BioTech Health X
  • July 21, 2025
GlucoTrack Inc. (NASDAQ:GCTK) is a medical technology company revolutionizing diabetes management through the development of its innovative continuous…
Read More
0 Shares
0
0
0
0
0
0
0

Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?

  • BioTech Health X
  • July 20, 2025
Pasithea Therapeutics Corp. (NASDAQ:KTTA) is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for central…
Read More
0 Shares
0
0
0
0
0
0
0

CNS Pharmaceuticals (CNSP) Might Be 2025’s Most Explosive Biotech Play

  • BioTech Health X
  • July 20, 2025
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel treatments…
Read More
0 Shares
0
0
0
0
0
0
0

Nature’s Sunshine (NATR) is Crushing Expectations—Is a 2025 Rally Imminent?

  • BioTech Health X
  • July 20, 2025
Nature’s Sunshine Products Inc. (NASDAQ:NATR) is a global leader in the natural health and wellness industry, known for…
Read More
0 Shares
0
0
0
0
0
0
0

The Honest Company (HNST) Could Be Wall Street’s Most Underrated Clean Brand Stock Right Now

  • BioTech Health X
  • July 20, 2025
The Honest Company Inc. (NASDAQ:HNST) is a mission-driven consumer goods company that has redefined the standards of transparency,…
Read More
0 Shares
0
0
0
0
0
0
0

Tivic Health (TIVC) Could Skyrocket in 2025

  • BioTech Health X
  • July 18, 2025
Tivic Health Systems, Inc. (NASDAQ:TIVC) is a forward-looking healthcare technology company headquartered in Fremont, California, dedicated to transforming…
Read More
0 Shares
0
0
0
0
0
0
0

Axogen (AXGN) is Reinventing Nerve Repair—And It Could Make Early Investors Rich

  • BioTech Health X
  • July 18, 2025
Axogen Inc. (NASDAQ:AXGN) is a pioneering medical technology company dedicated to improving the lives of patients suffering from…
Read More
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Evoke Pharma (EVOK) Faces Harsh Reality—Can it Avoid Collapse?
  • BBIO Stock Alert: Can BridgeBio Pharma Survive Its Cash Burn?
  • Kala Pharma (KALA) Faces Make-or-Break 2025—Will It Survive?
  • Edgewise Therapeutics (EWTX) Warning: Is This Headed for a Collapse?
  • Mind Medicine (MNMD) Price Target Raised – Analysts See 700% Upside
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 24, 2025
    Evoke Pharma (EVOK) Faces Harsh Reality—Can it Avoid Collapse?
    • August 24, 2025
    BBIO Stock Alert: Can BridgeBio Pharma Survive Its Cash Burn?
    • August 24, 2025
    Kala Pharma (KALA) Faces Make-or-Break 2025—Will It Survive?
    • August 24, 2025
    Edgewise Therapeutics (EWTX) Warning: Is This Headed for a Collapse?
    Breakthrough in Alzheimers Treatment Biogen and Eisais Leqembi Wins UK Approval
    • August 24, 2025
    Mind Medicine (MNMD) Price Target Raised – Analysts See 700% Upside
Recent Posts
  • Nutex Health (NUTX) Could Crash If Compliance Plan Fails
    • August 24, 2025
  • Corcept Therapeutics (CORT) Crashed Monday – Is This the Start of a Bigger Selloff?
    • August 24, 2025
  • ARS Pharmaceuticals (SPRY)Reports $15.7M Q2 Revenue
    • August 24, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (335)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top